Procurement Summary
Country: USA
Summary: Midazolam Autoinjectors Project Bioshield
Deadline: 06 Nov 2020
Posting Date: 23 Oct 2020
Other Information
Notice Type: Tender
TOT Ref.No.: 46827128
Document Ref. No.: 75A50121R00003
Competition: ICB
Financier: Self Financed
Purchaser Ownership: -
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Midazolam Autoinjectors Project Bioshield
Active Contract Opportunity
Notice ID : 75A50121R00003
Related Notice : BARDA-2020-Midazolam-Autoinjectors(01B)
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office : ASPR BARDA DIV CONTRACTS MGMT & ACQ
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Oct 22, 2020 01:10 pm EDT
Original Response Date: Nov 06, 2020 03:00 pm EST
Inactive Policy: 15 days after response date
Original Inactive Date: Nov 21, 2020
Initiative: None
Classification
Original Set Aside:
Product Service Code: AN11 - R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Place of Performance:
Description
The Department of Health and Human Services (HHS) has the responsibility of maintaining a definitive supply of medical Countermeasures for use in public health emergencies.The 2007 PHEMCE Implementation Plan for Chemical, Biological, Radiological, and Nuclear (CBRN) Threats called for updating the CHEMPACK formulary with improved medical countermeasures, such as anticonvulsants, as they became available. In 2011, the Public Health Emergency Medical Countermeasure Enterprise (PHEMCE) recomm...
Documents
Tender Notice